Candel Therapeutics (CADL) Treasury Shares (2022 - 2025)

Candel Therapeutics has disclosed Treasury Shares across 4 years of filings, most recently posting $448000.0 for Q4 2025.

• Treasury Shares for Q4 2025 came in at $448000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Dec 2025 was $448000.0 (changed 0.0% YoY), and the FY2025 annual result was $448000.0, changed 0.0% from the prior year.
• Treasury Shares came in at $448000.0 for Q4 2025 at Candel Therapeutics, roughly flat from $448000.0 in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $1.2 million in Q3 2024 to a low of -$122608.0 in Q4 2023.
• The 4-year median for Treasury Shares is $122608.0 (2022), against an average of $280419.3.
• Peak annual rise in Treasury Shares reached 0.0% in 2023, while the deepest fall reached 0.0% in 2023.
• Candel Therapeutics' Treasury Shares stood at $448000.0 in 2022, then changed by 0.0% to $448000.0 in 2023, then changed by 0.0% to $448000.0 in 2024, then changed by 0.0% to $448000.0 in 2025.
• The last three Treasury Shares figures came in at $448000.0 (Q4 2025), $448000.0 (Q3 2025), and $448000.0 (Q2 2025), per Business Quant data.